Lista de obras - Loris Riccardo Lopetuso - Dominio Público Uruguay

A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn's disease patients

artículo científico publicado en 2020

Actinobacteria: A relevant minority for the maintenance of gut homeostasis

artículo científico publicado en 2018

Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

artículo científico publicado en 2013

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases? ⬇️

artículo científico publicado en 2019

Beyond the HLA Genes in Gluten-Related Disorders

artículo científico publicado en 2020

Can We Predict the Efficacy of Anti-TNF-α Agents?

artículo científico publicado en 2017

Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center

artículo científico publicado en 2019

Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment

scientific article published on 23 September 2020

Commentary to "Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease"

scientific article published on 01 July 2019

Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase

artículo científico publicado en 2020

Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action.

artículo científico publicado en 2015

Epidemiology of inflammatory bowel disease in the Republic of San Marino: The "EPIMICI - San Marino" study

scientific article published on 20 August 2018

Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinoma

scientific article published on 05 May 2020

Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals

scientific article published on 20 March 2018

Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma

artículo científico publicado en 2020

Fecal transplantation for ulcerative colitis: current evidence and future applications

artículo científico publicado en 2020

Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease

artículo científico publicado en 2020

Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition ⬇️

artículo científico publicado en 2019

Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD?

artículo científico publicado en 2014

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases

artículo científico publicado en 2020

Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders?

artículo científico publicado en 2017

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility

artículo científico publicado en 2013

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver

artículo científico publicado en 2018

Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: a case report and review of the literature

scientific article published on 24 March 2020

IBD patients with COVID-19: the picture is taking shape

scientific article published on 18 August 2020

IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair

article published in the Proceedings of the National Academy of Sciences of the United States of America

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

artículo científico publicado en 2020

Impact of the Trophic Effects of the Secretome From a Multistrain Probiotic Preparation on the Intestinal Epithelia

scientific article published on 10 December 2020

Letter to the Editor: Winter is coming and COVID-19 vaccine is available! The role of gastroenterologist in increasing COVID-19 vaccine acceptability among IBD patients

artículo científico publicado en 2021

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

artículo científico publicado en 2013

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study

scientific article published on 28 September 2020

Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's Disease

artículo científico publicado en 2018

Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?

artículo científico publicado en 2016

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide.

scientific article published on 03 January 2017

Proteobacteria: A Common Factor in Human Diseases.

artículo científico publicado en 2017

Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.

artículo científico publicado en 2018

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

artículo científico publicado en 2016

Role of microbiota and innate immunity in recurrent Clostridium difficile infection.

artículo científico publicado en 2014

The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications

artículo científico publicado en 2020

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center

artículo científico publicado en 2020

Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila

artículo científico publicado en 2020

[Microbiota and inflammatory bowel disease: an update.]

scientific article published on 01 December 2018

for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

artículo científico publicado en 2018

Lista de obras de Loris Riccardo Lopetuso

A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn's disease patients

Actinobacteria: A relevant minority for the maintenance of gut homeostasis

Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases? ⬇️

Beyond the HLA Genes in Gluten-Related Disorders

Can We Predict the Efficacy of Anti-TNF-α Agents?

Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center

Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment

Commentary to "Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease"

Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase

Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action.

Epidemiology of inflammatory bowel disease in the Republic of San Marino: The "EPIMICI - San Marino" study

Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinoma

Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals

Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma

Fecal transplantation for ulcerative colitis: current evidence and future applications

Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease

Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition ⬇️

Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD?

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases

Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders?

Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver

Human herpesvirus 8-associated colonic Kaposi's sarcoma during vedolizumab treatment in ulcerative colitis: a case report and review of the literature

IBD patients with COVID-19: the picture is taking shape

IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Impact of the Trophic Effects of the Secretome From a Multistrain Probiotic Preparation on the Intestinal Epithelia

Letter to the Editor: Winter is coming and COVID-19 vaccine is available! The role of gastroenterologist in increasing COVID-19 vaccine acceptability among IBD patients

Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study

Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's Disease

Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide.

Proteobacteria: A Common Factor in Human Diseases.

Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

Role of microbiota and innate immunity in recurrent Clostridium difficile infection.

The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center

Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila

[Microbiota and inflammatory bowel disease: an update.]

for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials